A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has revealed that the now-available test remains just as accurate without it, paving ...

With rising global cancer rates necessitating new forms of diagnosis and treatment, Hong Kong-based biotech startup Phase Scientific International announced Tuesday it raised $34 million in a Series A ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade ...

Jeffrey Tosoian, MD, assistant professor of Urology and director of Translational Cancer Research at Vanderbilt University Medical Center. The results are important because this could enable at-home ...

Please provide your email address to receive an email when new articles are posted on . MyProstateScore 2.0 showed high sensitivity for detecting aggressive prostate cancer without the need for a ...

This was a pilot-controlled trial carried out among 72 patients (34 cases and 38 controls) in southwestern Nigeria. The cases were those with histopathological diagnosis of CRC while controls were ...

For decades, the story of prostate cancer screening has been dominated by three letters: P-S-A. The Prostate-Specific Antigen blood test is the first line of defense for millions of men. Yet, for all ...

An experimental urine test can detect aggressive prostate cancers in men on active surveillance, potentially sparing them from repeated biopsies, researchers reported on Friday. The MPS2-AS test is ...

In the cross-sectional cohort, the semi-quantitative ACR had a sensitivity of 78.1% and a specificity of 93.3% at a 30 mg/g creatinine cutoff, with over 90% overall agreement with quantitative ACR ...